BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15647107)

  • 1. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
    Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells.
    Barton BE; Murphy TF; Adem P; Watson RA; Irwin RJ; Huang HF
    BMC Cancer; 2001; 1():19. PubMed ID: 11710966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
    Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
    Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
    Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z; Lou W; Leman ES; Gao AC
    Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
    Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
    Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice.
    DeMiguel F; Lee SO; Lou W; Xiao X; Pflug BR; Nelson JB; Gao AC
    Prostate; 2002 Jul; 52(2):123-9. PubMed ID: 12111703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells.
    Zushi S; Shinomura Y; Kiyohara T; Miyazaki Y; Kondo S; Sugimachi M; Higashimoto Y; Kanayama S; Matsuzawa Y
    Int J Cancer; 1998 Oct; 78(3):326-30. PubMed ID: 9766567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS; Nagle RB; Bowden GT
    Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA; Chung LW
    Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.